Supplementary Table S1 from A Peptide-Based PROTAC Degrader of BRCA2 Sensitizes Metastatic Castration-Resistant Prostate Cancer to PARP Inhibition

<p>Supplementary Table S1. Clinical information of the PDX model.</p>

Guardat en:

Dades bibliogràfiques
Autor principal:	Qi Ye (22247095) (author)
Altres autors:	Bohan Ma (22247098) (author), Lei Li (22247101) (author), Zixi Wang (22247104) (author), Mingming Lu (22247107) (author), Jialu Kang (22247110) (author), Yuzeshi Lei (22247113) (author), Shan Xu (22247116) (author), Ke Wang (22247119) (author), Yanlin Jian (22247122) (author), Yizeng Fan (22247125) (author), Bin Wang (22247128) (author), Jing Liu (22247131) (author), Yang Gao (22247134) (author), Jian Ma (14960348) (author), Lei Li (22247137) (author)
Publicat:	2025
Matèries:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Biological Agents & Therapies Dna Damage And Repair Genitourinary Cancers Prostate cancer Nanoparticle Agents
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars